TimesSquare Capital Management LLC Trims Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

TimesSquare Capital Management LLC cut its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,100 shares of the company’s stock after selling 600 shares during the period. TimesSquare Capital Management LLC’s holdings in Acadia Healthcare were worth $552,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Vaughan Nelson Investment Management L.P. purchased a new position in Acadia Healthcare during the 4th quarter worth approximately $24,157,000. OFI Invest Asset Management boosted its holdings in Acadia Healthcare by 290.5% in the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock valued at $21,990,000 after purchasing an additional 246,322 shares during the last quarter. Jennison Associates LLC raised its stake in shares of Acadia Healthcare by 26.1% during the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after buying an additional 238,114 shares during the last quarter. California Public Employees Retirement System boosted its stake in shares of Acadia Healthcare by 112.6% in the third quarter. California Public Employees Retirement System now owns 368,382 shares of the company’s stock worth $25,901,000 after buying an additional 195,130 shares during the last quarter. Finally, Kingdon Capital Management L.L.C. acquired a new stake in Acadia Healthcare during the third quarter worth about $12,058,000.

Acadia Healthcare Trading Up 6.7 %

Shares of ACHC stock traded up $4.43 during trading hours on Thursday, hitting $70.49. The company had a trading volume of 1,811,318 shares, compared to its average volume of 639,048. Acadia Healthcare Company, Inc. has a fifty-two week low of $64.74 and a fifty-two week high of $87.77. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The company’s fifty day moving average is $75.67 and its 200 day moving average is $77.32. The stock has a market capitalization of $6.54 billion, a PE ratio of -503.50, a price-to-earnings-growth ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business’s quarterly revenue was up 9.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 earnings per share. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, March 5th. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a report on Thursday, April 25th. UBS Group lifted their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $88.89.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 2.00% of the company’s stock.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.